Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Upper Respiratory Tract Infection Treatment Market: By Type: Antibiotics, Nonsteroidal Anti-Inflammatory Drugs (Nsaids) And Nasal Decongestants, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Upper Respiratory Tract Infection Treatment Market Outlook

The global upper respiratory tract infection treatment market is estimated to grow at a CAGR of almost 3.8% in the forecast period of 2021-2026. The global upper respiratory tract infection treatment industry is driven by the rise in the demand for and availability of over-the-counter drugs, coupled with the advent of biologics.

 

Global Upper Respiratory Tract Infection Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infection commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, otitis media, and the common cold. This can be treated using various drugs, targeting disease-causing pathogens like bacteria and viruses.

 

Global Upper Respiratory Tract Infection Treatment Market Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global upper respiratory tract infection treatment industry can be divided based on segments like types and regions.

  • Type:
    • Antibiotics
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Nasal Decongestants
    • Others

The EMR report looks into the regional upper respiratory tract infection treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Upper Respiratory Tract Infection Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The growing incidence of upper respiratory tract infections, the development of new drugs, and the increasing demand for over-the-counter drugs is aiding the growth of the upper respiratory tract infection treatment industry globally. With the advancement in technology and development in the treatment of upper respiratory tract infection, the industry is witnessing an increased growth. Further, the growing awareness regarding the treatment and the rising disposable income, especially in emerging economies, are expected to drive the industry growth over the forecast period.

The antibiotics segment, among other types, dominated the global upper respiratory tract infection treatment market in 2020, owing to its easy availability and effective results. Region-wise, while North America accounted for the highest share in the industry in 2020, the Asia Pacific is expected to grow at the fastest rate over the forecast period owing to the growing population and increased expenditure on health care services in the region.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global upper respiratory tract infection treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline Plc 
  • Merck & Co., Inc. (NYSE: MRK)
  • Pfizer Inc. 
  • Regeneron Pharmaceuticals Inc. 
  • Teva Pharmaceutical Industries Ltd. 
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Region
Breakup by Type Antibiotics, Nonsteroidal Anti-Inflammatory Drugs (Nsaids) And Nasal Decongestants, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GlaxoSmithKline Plc (LON: GSK), Merck & Co., Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Teva Pharmaceutical Industries Ltd. (TLV: TEVA), Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

Key Questions Answered in the Market Report

  • How has the global upper respiratory tract infection treatment industry performed in the previous years (2016-2020)?
  • What is the forecast assessment of the market for 2021-2026?
  • What are the major drivers for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major constraints for the historical (2016-2020) and forecast (2021-2026) periods?
  • What are the major price indicators of the global market?
  • What are the major demand indicators of the global market?
  • What is the degree of competition in the global market?
  • What are the major events and developments taking place within the industry globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraints
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Upper Respiratory Tract Infection Treatment Market Analysis
    6.1    Figure: Global Upper Respiratory Tract Infection Treatment Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Chart: Global Upper Respiratory Tract Infection Treatment Market Breakup by Type
        6.2.1    Antibiotics
        6.2.2    Nonsteroidal Anti-Inflammatory Drugs (Nsaids) And Nasal Decongestants
        6.2.3    Others
    6.3    Figure: Global Upper Respiratory Tract Infection Treatment Market by Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Antibiotics
        6.3.2    Nonsteroidal Anti-Inflammatory Drugs (Nsaids) And Nasal Decongestants
        6.3.3    Others
    6.4    Chart: Global Upper Respiratory Tract Infection Treatment Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Mexico
            6.4.4.3    Argentina
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5    Figure: Global Upper Respiratory Tract Infection Treatment Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Mexico
            6.5.4.3    Argentina
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    EMR’s Key Indicators for Demand
10    EMR’s Key Indicators for Price
11    Competitive Landscape & Supplier Analysis

    11.1    GlaxoSmithKline Plc (LON: GSK)
        11.1.1    Company Overview
        11.1.2    Financial Analysis
    11.2    Merck & Co., Inc. (NYSE: MRK)
        11.2.1    Company Overview
        11.2.2    Financial Analysis
    11.3    Pfizer Inc. (NYSE: PFE)
        11.3.1    Company Overview
        11.3.2    Financial Analysis
    11.4    Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)
        11.4.1    Company Overview
        11.4.2    Financial Analysis
    11.5    Teva Pharmaceutical Industries Ltd. (TLV: TEVA)
        11.5.1    Company Overview
        11.5.2    Financial Analysis
    11.6    Others
12    Industry Events and Developments

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER